Plain-English translation of NCT06155305 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new approach to personalize breast cancer treatment. Researchers will take a small sample of your tumor tissue and grow it in the laboratory, then test it against different chemotherapy drugs to see which ones work best for your specific cancer. The goal is to see whether this lab testing can accurately predict how your cancer will respond to the chemotherapy you'll actually receive.
Not all breast cancers respond the same way to chemotherapy, and doctors currently have limited tools to predict which treatment will work best for each patient before starting. This trial exists to determine whether testing your tumor cells in the lab can help doctors choose the most effective chemotherapy for you personally.
You likely qualify if…
You likely don't qualify if…
You will have a small needle biopsy to collect a tiny sample of your tumor tissue before starting chemotherapy. Researchers will grow this tissue in the lab and test it against various chemotherapy drugs to create a profile of which treatments your cancer is most sensitive to. You will also undergo standard imaging scans before and after your first two cycles of chemotherapy, and your tumor's response will be carefully measured. The study team will then compare how your tumor responded in the lab to how it responds in your body to see if the lab testing was accurate.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China